Chiron Capital Management, LLC Bristol Myers Squibb CO Transaction History

Chiron Capital Management, LLC

$114 Million
Q3 2025

A detailed history of Chiron Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Chiron Capital Management, LLC holds 283,373 shares of BMY stock, worth $13.3 Million. This represents 11.19% of its overall portfolio holdings.

Number of Shares

283,373

Previous 286,413 1.06%

Holding current value

$13.3 Million

Previous $13.3 Million 3.61%

% of portfolio

11.19%

Previous 11.78%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$43.31 - $48.98 $131,662 - $148,899	-3,040 Reduced 1.06%	283,373 $12.8 Million
Q2 2025 Aug 11, 2025	SELL	$44.12 - $59.6 $582,163 - $786,422	-13,195 Reduced 4.4%	286,413 $13.3 Million
Q1 2025 May 15, 2025	SELL	$53.9 - $63.11 $5.92 Million - $6.94 Million	-109,920 Reduced 26.84%	299,608 $18.3 Million
Q4 2024 Feb 13, 2025	SELL	$51.92 - $59.94 $1.82 Million - $2.1 Million	-35,078 Reduced 7.89%	409,528 $23.2 Million
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $308,475 - $402,511	-7,778 Reduced 1.72%	444,606 $23 Million

Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $227,976 - $300,135	5,664 Added 1.27%	452,384 $18.8 Million
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $100,997 - $114,512	2,105 Added 0.47%	446,720 $24.2 Million
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $1.22 Million - $1.45 Million	-25,095 Reduced 5.34%	444,615 $22.8 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $518,868 - $580,174	-8,963 Reduced 1.87%	469,710 $27.3 Million
Q2 2023 Jul 27, 2023	BUY	$63.71 - $70.74 $97,985 - $108,798	1,538 Added 0.32%	478,673 $30.6 Million
Q1 2023 Apr 21, 2023	SELL	$65.71 - $74.53 $592,244 - $671,738	-9,013 Reduced 1.85%	477,135 $33.1 Million
Q4 2022 Jan 23, 2023	SELL	$68.48 - $81.09 $2.46 Million - $2.92 Million	-35,991 Reduced 6.89%	486,148 $0
Q3 2022 Oct 13, 2022	SELL	$0.13 - $76.84 $1,957 - $1.16 Million	-15,058 Reduced 2.8%	522,139 $37.1 Million
Q2 2022 Jul 25, 2022	SELL	$72.62 - $79.98 $5.87 Million - $6.46 Million	-80,823 Reduced 13.08%	537,197 $41.4 Million
Q1 2022 Apr 18, 2022	SELL	$61.48 - $73.72 $5.88 Million - $7.05 Million	-95,696 Reduced 13.41%	618,020 $45.1 Million
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $19,843 - $23,132	-370 Reduced 0.05%	713,716 $44.5 Million
Q3 2021 Oct 21, 2021	BUY	$59.17 - $69.31 $2.96 Million - $3.47 Million	50,004 Added 7.53%	714,086 $42.3 Million
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $6.25 Million - $6.81 Million	-100,971 Reduced 13.2%	664,082 $44.4 Million
Q1 2021 May 18, 2021	SELL	$59.34 - $66.74 $439,946 - $494,810	-7,414 Reduced 0.96%	765,053 $48.3 Million
Q4 2020 Mar 05, 2021	SELL	$57.74 - $65.43 $670,476 - $759,773	-11,612 Reduced 1.48%	772,467 $47.9 Million
Q3 2020 Nov 19, 2020	BUY	$57.43 - $63.64 $45 Million - $49.9 Million	784,079 New	784,079 $47.3 Million

Others Institutions Holding BMY

# of Institutions

2,680

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chiron Capital Management, LLC with notifications on news.

Account

Chiron Capital Management, LLC Bristol Myers Squibb CO Transaction History